Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria von Ismail, Zahinoor, Gatchel, Jennifer, Bateman, Daniel R., Barcelos-Ferreira, Ricardo, Cantillon, Marc, Jaeger, Judith, Donovan, Nancy J., Mortby, Moyra E.

Volltext

Response to Aanwat et al. on chow et al. Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study JONS Ju... von Cantillon, Marc

Volltext

Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial von Hauser, Robert A, Prof, Cantillon, Marc, MD, Pourcher, Emmanuelle, Prof, Micheli, Federico, Prof, Mok, Vincent, MD, Onofrj, Marco, Prof, Huyck, Susan, DrPH, Wolski, Kenneth, MD

Volltext

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease von Jack, Clifford R, Barkhof, Frederik, Bernstein, Matt A, Cantillon, Marc, Cole, Patricia E, DeCarli, Charles, Dubois, Bruno, Duchesne, Simon, Fox, Nick C, Frisoni, Giovanni B, Hampel, Harald, Hill, Derek L.G, Johnson, Keith, Mangin, Jean-François, Scheltens, Philip, Schwarz, Adam J, Sperling, Reisa, Suhy, Joyce, Thompson, Paul M, Weiner, Michael, Foster, Norman L

Volltext

Relative antidepressant efficacy of venlafaxine and SSRIs: sex-age interactions von Thase, Michael E, Entsuah, Richard, Cantillon, Marc, Kornstein, Susan G

Volltext

Response to concerns over Cantillon et al. dopamine serotonin stabilizer RP5063 clinical trial's design, analyses and findings (SCHRES-D-17-00455) by Ahmed S Aboraya, MD, DrPh von Cantillon, Marc, Bhat, Laxminarayan

Volltext

Evaluation of the exposure equivalence of oral versus intravenous temozolomide von Diez, Blanca D, Statkevich, Paul, Zhu, Yali, Abutarif, Malaz A, Xuan, Fengjuan, Kantesaria, Bhavna, Cutler, David, Cantillon, Marc, Schwarz, Max, Pallotta, Maria Guadalupe, Ottaviano, Fabio H

Volltext

EFFICACY AND SAFETY OF NOVEL DOPAMINE SEROTONIN STABILIZER RP 5063 IN ACUTE SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER von Cantillon, Marc

Volltext

Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance von Stern, Yaakov, Arenaza-Urquijo, Eider M., Bartrés-Faz, David, Belleville, Sylvie, Cantilon, Marc, Chetelat, Gael, Ewers, Michael, Franzmeier, Nicolai, Kempermann, Gerd, Kremen, William S., Okonkwo, Ozioma, Scarmeas, Nikolaos, Soldan, Anja, Udeh-Momoh, Chinedu, Valenzuela, Michael, Vemuri, Prashanthi, Vuoksimaa, Eero, Arenaza Urquiljo, Eider M., Bartrés-Faz, David, Belleville, Sylvie, Cantillon, Marc, Chetelat, Gael, Clouston, Sean A.P., Estanga, Ainara, Ewers, Michael, Franzmeier, Nicolai, Gold, Brian, Habeck, Christian, Jones, Richard, Kempermann, Gerd, Kochhann, Renata, Kremen, William, Lim, Yen Ying, Martínez-Lage, Pablo, Morbelli, Silvia, Okonkwo, Ozioma, Ossenkoppele, Rik, Pettigrew, Corinne, Rosen, Allyson C., Scarmeas, Nikolaos, Soldan, Anja, Song, Xiaowei, Udeh-Momoh, Chinedu, Stern, Yaakov, Valenzuela, Michael, Van Loenhoud, Anita C., Vemuri, Prashanthi, Vuoksimaa, Eero

Volltext

Tricaprilin (CER-0001) for the preventive treatment of migraine: A phase 2 randomised, double-blind, placebo-controlled pilot study von Chow, Lilian, Presanis, Julia, McIntyre, Nikki, Henderson, Samuel, Bloch, Mark, Hutton, Elspeth, Cantillon, Marc

Volltext

Phase 1/2a Intravenous and Subcutaneous Oligomer-Specific Antibody KHK6640 in Mild to Moderate Alzheimer’s Disease von Cantillon, Marc, Andreasen, N., Prins, N.

Volltext

Dopamine serotonin stabilizer RP5063: A randomized, double-blind, placebo-controlled multicenter trial of safety and efficacy in exacerbation of schizophrenia or schizoaffective di... von Cantillon, Marc, Prakash, Arul, Alexander, Ajay, Ings, Robert, Sweitzer, Dennis, Bhat, Laxminarayan

Volltext

Alzheimer's-specific data standards von Cantillon, Marc

Volltext

F5‐03‐01: Alzheimer's‐specific data standards von Cantillon, Marc

Volltext

Pimavanserin for Treatment of Comorbid Depression in Patients With Parkinson’s Disease (4516) von Guskey, Michael, Alva, Gustavo, Aldred, Jason, Coate, Bruce, Abler, Victor, Cantillon, Marc, Norton, James, DeKarske, Daryl

Volltext

Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia von Cantillon, Marc, Ings, Robert, Bhat, Laxminarayan

Volltext

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials von Mortby, Moyra E., Adler, Lawrence, Agüera-Ortiz, Luis, Bateman, Daniel R., Brodaty, Henry, Cantillon, Marc, Geda, Yonas E., Ismail, Zahinoor, Lanctôt, Krista L., Marshall, Gad A., Padala, Prasad R., Politis, Antonios, Rosenberg, Paul B., Siarkos, Kostas, Sultzer, David L., Theleritis, Christos

Volltext

RP5063, an atypical antipsychotic drug with a unique pharmacologic profile, improves declarative memory and psychosis in mouse models of schizophrenia von Rajagopal, Lakshmi, Kwon, Sunoh, Huang, Mei, Michael, Eric, Bhat, Laxminarayan, Cantillon, Marc, Meltzer, Herbert Y.

Volltext

A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia von Xiao, Shifu, Chan, Piu, Wang, Tao, Hong, Zhen, Wang, Shuzhen, Kuang, Weihong, He, Jincai, Pan, Xiaoping, Zhou, Yuying, Ji, Yong, Wang, Luning, Cheng, Yan, Peng, Ying, Ye, Qinyong, Wang, Xiaoping, Wu, Yuncheng, Qu, Qiumin, Chen, Shengdi, Li, Shuhua, Chen, Wei, Xu, Jun, Peng, Dantao, Zhao, Zhongxin, Li, Yansheng, Zhang, Junjian, Du, Yifeng, Chen, Weixian, Fan, Dongsheng, Yan, Yong, Liu, Xiaowei, Zhang, Wei, Luo, Benyan, Wu, Wenyuan, Shen, Lu, Liu, Chunfeng, Mao, Peixian, Wang, Qiumei, Zhao, Qianhua, Guo, Qihao, Zhou, Yongtao, Li, Yi, Jiang, Lijun, Ren, Wenwei, Ouyang, Yingjun, Wang, Yan, Liu, Shuai, Jia, Jianjun, Zhang, Nan, Liu, Zhonglin, He, Raoli, Feng, Tingyi, Lu, Wenhui, Tang, Huidong, Gao, Ping, Zhang, Yingchun, Chen, Lanlan, Wang, Lei, Yin, You, Xu, Qun, Xiao, Jinsong, Cong, Lin, Cheng, Xi, Zhang, Hui, Gao, Dan, Xia, Minghua, Lian, Tenghong, Peng, Guoping, Zhang, Xu, Jiao, Bin, Hu, Hua, Chen, Xueyan, Guan, Yihui, Cui, Ruixue, Huang, Qiu, Xin, Xianliang, Chen, Hongjian, Ding, Yu, Zhang, Jing, Feng, Teng, Cantillon, Marc, Chen, Kewei, Cummings, Jeffrey L, Ding, Jian, Geng, Meiyu, Zhang, Zhenxin

Volltext

Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients von Cantillon, Marc, Ings, Robert, Bhat, Laxminarayan

Volltext